Apellis Pharmaceuticals Appoints Thomas Lackner as Senior Vice President, Head of Europe
CRESTWOOD, Ky., WALTHAM, Mass. and ZUG, Switzerland, Jan. 31, 2019 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical […]